These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22237669)

  • 1. Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?
    Avery RL
    J AAPOS; 2012 Feb; 16(1):2-4. PubMed ID: 22237669
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Avastin the right choice of treatment for retinopathy of prematurity?
    Käll A
    Acta Paediatr; 2012 Aug; 101(8):796-8. PubMed ID: 22788788
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".
    Er H
    Retina; 2009 Oct; 29(9):1380; author reply 1379-80. PubMed ID: 19934833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alarming use of anti-VEGF therapy in premature infants].
    Hård AL; Hellström A
    Lakartidningen; 2011 Dec 7-13; 108(49):2600. PubMed ID: 22468401
    [No Abstract]   [Full Text] [Related]  

  • 5. Off-label use of bevacizumab in retinopathy of prematurity.
    Rishi E; Rishi P; Ratra D; Bhende M
    Retina; 2009 Feb; 29(2):284; author reply 284-5. PubMed ID: 18854784
    [No Abstract]   [Full Text] [Related]  

  • 6. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
    Tseng CC; Chen SN; Hwang JF; Lin CJ
    J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
    Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
    J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review.
    Hård AL; Hellström A
    Acta Paediatr; 2011 Dec; 100(12):1523-7. PubMed ID: 21854449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.
    Patel RD; Blair MP; Shapiro MJ; Lichtenstein SJ
    Arch Ophthalmol; 2012 Jun; 130(6):801-2. PubMed ID: 22801851
    [No Abstract]   [Full Text] [Related]  

  • 10. Avastin as monotherapy for retinopathy of prematurity.
    Mintz-Hittner HA
    J AAPOS; 2010 Feb; 14(1):2-3. PubMed ID: 20227612
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
    Spandau U
    Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
    [No Abstract]   [Full Text] [Related]  

  • 12. [DOG (German Ophthalmological Society): retinopathy of prematurity best possible treatment. Antibody therapy - only advisable in certain cases].
    Voormann AJ
    Kinderkrankenschwester; 2012 Jun; 31(6):237. PubMed ID: 22808670
    [No Abstract]   [Full Text] [Related]  

  • 13. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
    Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
    J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab (avastin) for the treatment of retinopathy of prematurity.
    Beaulieu MJ
    Neonatal Netw; 2012; 31(4):242-7. PubMed ID: 22763251
    [No Abstract]   [Full Text] [Related]  

  • 15. Bevacizumab for retinopathy of prematurity.
    Gole GA; Camuglia JE; Ells AL
    N Engl J Med; 2011 Jun; 364(24):2360-1; author reply 2362. PubMed ID: 21675896
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity.
    de Klerk TA; Park DY; Biswas S
    Eye (Lond); 2013 Oct; 27(10):1218. PubMed ID: 23846376
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
    Flavahan PW; Lavy TE; Wykes W
    Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
    Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
    Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence of retinopathy of prematurity following bevacizumab monotherapy: is it only the tip of the iceberg?
    Mireskandari K; Adams GG; Tehrani NN
    JAMA Ophthalmol; 2013 Apr; 131(4):544-5. PubMed ID: 23579608
    [No Abstract]   [Full Text] [Related]  

  • 20. [Retinopathy of prematurity].
    Jandeck C; Stahl A
    Klin Monbl Augenheilkd; 2012 May; 229(5):559-75; quiz 576-7. PubMed ID: 22592347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.